Hypertension (high blood pressure) — all decisions

The Board denied the Veteran's claims for a compensable evaluation for hypertension and erectile dysfunction.

The Board granted service connection for hypertension, Parkinson's disease, cryptococcal infection, and sarcoidosis as secondary to the cryptococcal infection. COPD was also granted as secondary to both cryptococcal infection and Parkinson's disease.

The Board remands the claims for service connection for hypertension, an initial compensable rating for chronic bronchitis, and a total disability rating based on individual unemployability due to service-connected disability (TDIU) as additional development is necessary.

The Board denied the Veteran's claim for an increased rating for service-connected hypertension, as the evidence did not show a diastolic pressure predominantly 100 or more or systolic pressure predominantly 160 or more.

The Board denied the Veteran's claim for service connection for hypertension, finding no evidence of an in-service injury or disease and a prolonged period without complaint or diagnosis.

The appeal of the November 2024 rating decision denying a compensable rating for hypertension was dismissed due to an impermissible concurrent election.

The Board denied service connection for multiple disabilities, including a right hip disability, left ankle disability, right trigger finger disability, acquired psychiatric disorder, obstructive sleep apnea (OSA), and hypertension.

The Board granted service connection for diabetes mellitus, type II, a heart condition, and hypertension as secondary to the Veteran's service-connected acquired psychiatric disorder.

The Board remands the claims for service connection for various conditions, including right shoulder strain, left shoulder disorder, right knee disorder, left knee minimal degenerative joint disease with patellar tendinitis and bursitis, vertigo, congestive heart failure, and hypertension, to correct duty-to-assist errors.

The Board denied service connection for a left meniscus tear, right knee instability, chronic sinusitis or other condition of the nose, throat, larynx and pharynx, diabetes, type 1 or type 2, hypertension (high blood pressure), tinnitus, and visual impairment, including blurry vision, blindness and double vision.

The Board granted service connection for hypertension as secondary to the service-connected Type II diabetes mellitus but denied service connection for right knee arthritis.

The Board denied service connection for degenerative arthritis and spinal stenosis, lumbar spine, left hand nerve damage, right hand nerve damage, right lower extremity (RLE) nerve damage, and left lower extremity (LLE) nerve damage. The claim for a compensable rating for hypertension prior to March 8, 2024, was also denied.

The Board denied the veteran's claim for service connection for hypertension, finding that there was no evidence of a relationship between the condition and his service or his service-connected posttraumatic stress disorder (PTSD).

The Veteran is granted a total disability rating based on individual unemployability (TDIU) and an effective date of August 13, 2019, for the grant of Special Monthly Compensation (SMC) based on the need for aid and attendance.

The Board remands all claims for service connection to the AOJ for further development, including obtaining relevant VA and private medical records and scheduling a VA examination.

The Board granted service connection for hypertension as it is proximately caused by the Veteran's service-connected degenerative arthritis osteophyte vertebrae L5.

The Board granted service connection for obstructive sleep apnea, degenerative disc disease, and hypertension based on the evidence being at least evenly balanced.

The Board denied service connection for diabetes mellitus, kidney disease, liver disease, and hypertension as the probative evidence did not establish a link between these conditions and the Veteran's period of active-duty service.

The Board granted service connection for coronary artery disease, hypertension, and chronic lymphocytic leukemia but denied it for hypothyroidism.

The Board denied an initial rating in excess of 10 percent for hypertension and granted a 10 percent rating for gastroesophageal reflux disease (GERD).